Market Overview:
The global medical consumables for diagnosis of interventional pulmonary diseases market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as rising prevalence of respiratory diseases, increasing demand for minimally invasive surgeries, and technological advancements in medical consumables. However, the high cost of advanced medical consumables may restrain the growth of this market during the forecast period. Based on type, the global medical consumables for diagnosis of interventional pulmonary diseases market can be segmented into suitable and not suitable for tumors. The suitable type segment is expected to account for a larger share than the not suitable type segment during the forecast period owing to its ability to detect small tumors and lesions with accuracy. Based on application, clinics are expected to account for a larger share than hospitals in terms of revenue generated by this market during the forecast period due their growing popularity among patients across regions worldwide.
Product Definition:
Medical Consumables for Diagnosis of Interventional Pulmonary Diseases is a device used to diagnose or treat a medical condition. It is important because it helps doctors accurately diagnose and treat patients.
Suitable for Tumors:
The global Suitable for Tumors, it's usage and growth factor in Medical Consumables for Diagnosis of Interventional Pulmonary diseases market size was valued at USD 1.5 billion in 2017. It is anticipated to expand at a CAGR of XX% during the forecast period. The rising prevalence of chronic respiratory diseases coupled with increasing geriatric population base is expected to drive the demand over the coming years.
Not suitable for tumors:
The main objective of using nanoparticles in medical consumables for diagnosis of interventional pulmonary diseases is to deliver the drug at the site of action. The most commonly used nanomaterials are gold, silver, and carbon with a size range from 1 to 10 nm. These materials are used as coating agents for liposomes, monoclonal antibodies or as an encapsulation agent for drugs or DNA fragments.
Application Insights:
Based on application, the market is segmented into clinics, hospitals and others. The clinics segment dominated the overall market in terms of revenue in 2017. This can be attributed to increasing prevalence of chronic diseases and growing demand for faster diagnostic solutions at low costs. However, this segment is expected to lose share over the forecast period owing to rising awareness about availability of advanced diagnostics equipment and technologies at lower cost in hospitals compared to clinics.
The hospital application segment is also anticipated to witness significant growth over the forecast period due largelyto factors such as an increase in numberof procedures involving IPDs coupled with rising prevalenceand complexity of interventional pulmonary diseases across various regions globally.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies, and favorable reimbursement policies for interventional procedures. In addition, increasing prevalence of lung cancer and other respiratory diseases is expected to drive regional growth during the forecast period.
In 2016, according with The World Bank Group (WB), around USD X billion was spent on hospital care in Japan while around USD X billion was spent on hospitalization expenses in India during that year alone.
Growth Factors:
- Increasing incidence of interventional pulmonary diseases
- Rising demand for minimally invasive surgeries
- Technological advancements in medical consumables for diagnosis of interventional pulmonary diseases
- Growing awareness about the benefits of early diagnosis and treatment of interventional pulmonary diseases
- Increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Consumables for Diagnosis of Interventional Pulmonary Diseases Market Research Report
By Type
Suitable for Tumors, Not suitable for tumors
By Application
Clinics, Hospitals, Others
By Companies
Broncus Medical, Medtronic, Nuvaira Inc, Balmer Medical, Boston Scientific Corporation, Olympus
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
204
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Medical Consumables for Diagnosis of Interventional Pulmonary Diseases Market Report Segments:
The global Medical Consumables for Diagnosis of Interventional Pulmonary Diseases market is segmented on the basis of:
Types
Suitable for Tumors, Not suitable for tumors
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinics, Hospitals, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Broncus Medical
- Medtronic
- Nuvaira Inc
- Balmer Medical
- Boston Scientific Corporation
- Olympus
Highlights of The Medical Consumables for Diagnosis of Interventional Pulmonary Diseases Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Suitable for Tumors
- Not suitable for tumors
- By Application:
- Clinics
- Hospitals
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Consumables for Diagnosis of Interventional Pulmonary Diseases Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical consumables for diagnosis of interventional pulmonary diseases include bronchoscopes, biopsies, and other diagnostic tools.
Some of the major companies in the medical consumables for diagnosis of interventional pulmonary diseases market are Broncus Medical, Medtronic, Nuvaira Inc, Balmer Medical, Boston Scientific Corporation, Olympus.
The medical consumables for diagnosis of interventional pulmonary diseases market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Medical Consumables for Diagnosis of Interventional Pulmonary Diseases Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Medical Consumables for Diagnosis of Interventional Pulmonary Diseases Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Medical Consumables for Diagnosis of Interventional Pulmonary Diseases Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Medical Consumables for Diagnosis of Interventional Pulmonary Diseases Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Medical Consumables for Diagnosis of Interventional Pulmonary Diseases Market Size & Forecast, 2020-2028
4.5.1 Medical Consumables for Diagnosis of Interventional Pulmonary Diseases Market Size and Y-o-Y Growth
4.5.2 Medical Consumables for Diagnosis of Interventional Pulmonary Diseases Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Suitable for Tumors
5.2.2 Not suitable for tumors
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Clinics
6.2.2 Hospitals
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Medical Consumables for Diagnosis of Interventional Pulmonary Diseases Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Medical Consumables for Diagnosis of Interventional Pulmonary Diseases Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Suitable for Tumors
9.6.2 Not suitable for tumors
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Clinics
9.10.2 Hospitals
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Suitable for Tumors
10.6.2 Not suitable for tumors
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Clinics
10.10.2 Hospitals
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Suitable for Tumors
11.6.2 Not suitable for tumors
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Clinics
11.10.2 Hospitals
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Suitable for Tumors
12.6.2 Not suitable for tumors
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Clinics
12.10.2 Hospitals
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Suitable for Tumors
13.6.2 Not suitable for tumors
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Clinics
13.10.2 Hospitals
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Medical Consumables for Diagnosis of Interventional Pulmonary Diseases Market: Competitive Dashboard
14.2 Global Medical Consumables for Diagnosis of Interventional Pulmonary Diseases Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Broncus Medical
14.3.2 Medtronic
14.3.3 Nuvaira Inc
14.3.4 Balmer Medical
14.3.5 Boston Scientific Corporation
14.3.6 Olympus
